Vit D and PD-1 Blockade; Low Implant-Related SCC Risk; Better Pay for Unused Meds
(MedPage Today) -- Patients with advanced melanoma had a higher response rate with immunotherapy when they had normal vitamin D levels either at baseline or through supplementation. (Cancer)
Foghorn Therapeutics announced a pause in enrollment...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Cancer | Cancer & Oncology | Hematology | Immunotherapy | Melanoma | Skin Cancer | Vitamin D | Vitamins